Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Synergistic Interaction Between Proton Pump Inhibitors and Resistance Modifiers: Promoting Effects of Antibiotics and Plasmid Curing

KRISTINA WOLFART, GABRIELLA SPENGLER, MASAMI KAWASE, NOBORU MOTOHASHI, JOSEPH MOLNÁR, MIGUEL VIVEIROS and LEONARD AMARAL
In Vivo May 2006, 20 (3) 367-372;
KRISTINA WOLFART
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GABRIELLA SPENGLER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAMI KAWASE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NOBORU MOTOHASHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOSEPH MOLNÁR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIGUEL VIVEIROS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LEONARD AMARAL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: LAmaral{at}ihmt.unl.pt
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

A proton pump-deleted mutant E. coli, AG100 A, had greater sensitivity to ampicillin, tetracycline and erythromycin than the wild-type parent E. coli AG100 containing the proton pump. This antibiotic sensitivity was further increased by resistance modifiers such as the Ca2+ channel blocker (±) verapamil (VP) and the calmodulin antagonist promethazine (PMZ). Whereas the newly-synthesized trifluoromethyl-ketone (TF) enhanced the activity of these antibiotics against the wild-type strain, it did not enhance the activity of ampicillin against the proton pump-deleted mutant. These results suggested that TF14 had an inhibitory effect on the proton pump. Elimination of plasmids from another strain of E. coli, K12, was promoted by PMZ and 9-amino-acridine (9-AA), but not by TF14 alone. However, combinations of TF14 with either PMZ or 9-AA enhanced the plasmid elimination capacity of the latter compounds. The combination of TF14, PMZ and VP proved that the Ca2+ channel blocker was not effective by itself. These results collectively suggest that TF14 inhibited the proton pump of E. coli and that it was this pump which, when inhibited by TF14, allowed more PMZ to reach its plasmid elimination target.

  • Proton pump
  • resistance modifiers
  • trifluoromethyl-ketones
  • E. coli
  • multidrug resistance
  • bacterial transporters
  • plasmid curing

Footnotes

  • Received December 8, 2005.
  • Revision received February 22, 2006.
  • Accepted February 28, 2006.
  • Copyright © 2006 The Author(s). Published by the International Institute of Anticancer Research.
PreviousNext
Back to top

In this issue

In Vivo
Vol. 20, Issue 3
May-June 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synergistic Interaction Between Proton Pump Inhibitors and Resistance Modifiers: Promoting Effects of Antibiotics and Plasmid Curing
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Synergistic Interaction Between Proton Pump Inhibitors and Resistance Modifiers: Promoting Effects of Antibiotics and Plasmid Curing
KRISTINA WOLFART, GABRIELLA SPENGLER, MASAMI KAWASE, NOBORU MOTOHASHI, JOSEPH MOLNÁR, MIGUEL VIVEIROS, LEONARD AMARAL
In Vivo May 2006, 20 (3) 367-372;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Synergistic Interaction Between Proton Pump Inhibitors and Resistance Modifiers: Promoting Effects of Antibiotics and Plasmid Curing
KRISTINA WOLFART, GABRIELLA SPENGLER, MASAMI KAWASE, NOBORU MOTOHASHI, JOSEPH MOLNÁR, MIGUEL VIVEIROS, LEONARD AMARAL
In Vivo May 2006, 20 (3) 367-372;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Halogenated Antimicrobial Agents to Combat Drug-Resistant Pathogens
  • Common Garlic (Allium sativum L.) has Potent Anti-Bacillus anthracis Activity
  • Antibacterial Properties of an Oligo-Acyl-Lysyl Hexamer Targeting Gram-Negative Species
  • Potentiating Effect of Mentha arvensis and Chlorpromazine in the Resistance to Aminoglycosides of Methicillin - Resistant Staphylococcus aureus
  • Google Scholar

More in this TOC Section

  • Differential Influence of Morinda citrifolia L. Fruit Juice on the Molecular Composition of Human Platelet Rich Fibrin
  • Establishment of a Step-down FSH Superovulation Protocol in Microminipigs for Zygote Collection
  • Modulating ACVRL1 Expression in HMEC1 Cells as a Simplified In Vitro Model for Hereditary Hemorrhagic Telangiectasia (HHT) Type 2 Studies
Show more Experimental Studies
In Vivo

© 2026 In Vivo

Powered by HighWire